π **Comprehensive Guide on Zolpidem Tartrate API Manufactured by Swapnroop Drugs & Pharmaceuticals** ππ✨
Q1 — What is Zolpidem Tartrate API (manufactured by Swapnroop Drugs & Pharmaceuticals)? — π€π¬✨
Short definition (one line):
Zolpidem tartrate API is the active pharmaceutical ingredient used to make zolpidem-containing hypnotic (sleep) medications — a non-benzodiazepine GABA_A receptor modulator prescribed for short-term treatment of insomnia. ππ
Chemical & identity snapshot π§©
-
Common name: Zolpidem tartrate (API is the zolpidem base often supplied as the tartrate salt).
-
IUPAC name (zolpidem): N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide (tartrate is the salt form).
-
Molecular formula (zolpidem base): C19H21N3O
-
CAS number (zolpidem tartrate): 82626-48-0 (tartrate salt identifiers are commonly used in regulatory docs). π
-
Appearance: White to off-white crystalline powder (tartrate salt), free-flowing when properly dried. ❄️
If you need exact molar mass or alternate identifiers for regulatory filings, I can add them.
Pharmacology — mechanism of action ⚙️π§
-
Mechanism: Zolpidem is a positive allosteric modulator of GABA_A receptors, with preferential binding to the Ξ±1 subunit. This potentiates GABAergic inhibition in the CNS and produces hypnotic (sleep-inducing) effects.
-
Classification: Non-benzodiazepine “Z-drug” hypnotic (different chemical class but acts on the benzodiazepine binding site of GABA_A). π§¬
Therapeutic use (clinical role) π©Ίπ
-
Primary indication: Short-term management of insomnia — particularly for difficulty initiating sleep.
-
Typical clinical goal: Reduce sleep latency (time to fall asleep), and in some formulations help maintain sleep for a limited duration. ⏱️
-
Use constraints: Usually recommended for short durations (a few weeks) due to tolerance, dependence, and next-day impairment risks.
Key pharmaceutical attributes and why the API matters ✅
-
Salt form (tartrate) improves aqueous solubility and stability versus the free base, aiding formulation into tablets and oral dispersible forms.
-
Particle size & crystal form influence dissolution rate, content uniformity, and bioavailability — critical for a molecule with rapid onset expectations.
-
High purity & controlled residual solvents ensure patient safety and predictable pharmacokinetics. π§ͺ
Safety profile & precautions ⚠️
-
Common adverse effects: Drowsiness, dizziness, headache, somnolence, nausea, and coordination impairment. π΄
-
Serious/important risks: Complex sleep-related behaviors (sleepwalking, sleep-driving), next-day impairment, risk of dependence and withdrawal with prolonged use, and potential for respiratory depression especially when combined with CNS depressants (alcohol, opioids). π¨
-
Contraindications/Cautions: Severe hepatic impairment (dose adjustment or avoidance), history of complex sleep behaviors, concomitant use with strong CYP3A4 inhibitors/inducers may alter exposure. Use with caution in elderly (increased sensitivity; fall risk). π©Ή
Formulation & dosing relevance π
-
Typical strengths: 5 mg and 10 mg immediate-release tablets (strengths vary by market and patient population).
-
Onset expectation: Rapid absorption → fast onset of action; formulations are designed to dissolve and release zolpidem quickly for sleep initiation. ⚡
-
Implication for API: Fast dissolution performance required — particle engineering (micronization) and appropriate salt/crystal form control are important.
Quality & regulatory expectations π·️π
Customers expect zolpidem tartrate API to be supplied with:
-
Certificate of Analysis (CoA) showing assay, impurities, residual solvent results, moisture content, and microbial limits.
-
GMP compliance, batch traceability, and stability data suitable for dossier submission in regulated markets. π️
Packaging & storage (API commercial view) π¦π‘️
-
Packaging: Double-lined polyethylene bags inside HDPE or fiber drums (desiccant and light-resistant inner liner if moisture/light sensitive).
-
Storage: Cool, dry place; typically below 25°C and protected from moisture/light to maintain potency and prevent degradation. π§
Why Swapnroop’s supply matters to buyers π€
Buyers look for: robust impurity control, reproducible particle size, validated analytical methods, and documentation for regulatory filings. A consistent, pharmacopeial-grade zolpidem tartrate API from Swapnroop enables reliable finished products (tablets/ODTs) that perform predictably in patients. π¦✅
2️⃣ What is Zolpidem Tartrate API by Swapnroop Drugs & Pharmaceuticals used for?
π€ Primary Use:
Zolpidem Tartrate API is used in the manufacturing of hypnotic medications designed to treat insomnia, especially for patients who have difficulty falling asleep or maintaining sleep. π️
π§ Pharmacological Role:
It acts on the GABA-A receptor complex, enhancing the activity of GABA (the brain’s main inhibitory neurotransmitter). This results in CNS depression, leading to sedation, relaxation, and sleep induction.
π Therapeutic Applications:
-
Treatment of short-term insomnia π€
-
Managing sleep onset difficulties ⏱️
-
As part of pre-anesthetic medication in some clinical settings π
⚠️ Note: Long-term use is discouraged due to potential for tolerance and dependence.
3️⃣ What are the physicochemical properties of Zolpidem Tartrate API manufactured by Swapnroop Drugs & Pharmaceuticals?
π§ͺ Physicochemical Profile:
-
Chemical Name: N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide tartrate
-
Molecular Formula: C19H21N3O·C4H6O6
-
Molecular Weight: ~764.9 g/mol (tartrate salt) ⚖️
-
Appearance: White to off-white crystalline powder ❄️
-
Odor: Odorless
-
Taste: Slightly bitter
-
Solubility:
-
Freely soluble in water and methanol π§
-
Sparingly soluble in ethanol πΆ
-
Practically insoluble in non-polar solvents (e.g., hexane)
-
-
Melting Point: ~193–196°C π‘️
-
pKa: 6.2 (weakly basic)
-
Log P: ~2.2 (moderate lipophilicity)
-
Hygroscopicity: Slightly hygroscopic; requires dry storage π§΄
π¬ These properties make it ideal for oral solid dosage forms, as the tartrate salt ensures good solubility and bioavailability.
4️⃣ How is Zolpidem Tartrate API manufactured (synthesized) by Swapnroop Drugs & Pharmaceuticals?
⚗️ Synthesis Overview:
Zolpidem Tartrate is synthesized through a multi-step organic synthesis involving condensation, cyclization, and amidation reactions. Below is a general outline (simplified):
-
Formation of Imidazopyridine Core
-
The reaction between 2-amino-5-methylpyridine and benzoylacetate derivatives forms the imidazo[1,2-a]pyridine ring system π
-
-
N-Methylation
-
The imidazopyridine intermediate undergoes methylation at the nitrogen atom using a suitable methylating agent like dimethyl sulfate or methyl iodide π§ͺ
-
-
Acetamide Formation
-
Introduction of the acetamide side chain via acetylation or amidation reactions creates the active moiety responsible for hypnotic activity π§¬
-
-
Salt Formation (Tartrate)
-
The free base is converted into Zolpidem Tartrate by reaction with tartaric acid in a suitable solvent (e.g., ethanol or isopropanol). This enhances solubility and stability π§
-
-
Purification and Crystallization
-
The final API is purified by recrystallization and dried under controlled conditions to achieve pharmacopeial purity standards. π‘️
-
π Swapnroop’s Process Advantage:
-
Uses GMP-compliant synthesis
-
Validated analytical controls at each step
-
Focus on low residual solvent and controlled polymorphism for high-quality, stable API ✅
5️⃣ What are the different dosage forms of Zolpidem Tartrate manufactured using the API?
π Common Dosage Forms:
-
Immediate-Release Tablets (5 mg, 10 mg) — for quick sleep induction π
-
Extended-Release Tablets (ER) — for patients with difficulty maintaining sleep π
-
Oral Disintegrating Tablets (ODTs) — dissolve rapidly without water π§
-
Sublingual Tablets — for rapid absorption under the tongue π
-
Spray formulations or drops — newer forms for fast onset π¨
π§© Formulation depends on:
-
Desired onset and duration of action
-
Patient age and swallowing ability
-
Compliance and pharmacokinetic profile
6️⃣ How are Zolpidem Tartrate dosage forms prepared?
⚗️ General Preparation Process for Tablets (Example):
Step 1 – Blending:
Mix Zolpidem Tartrate API with excipients such as lactose monohydrate, microcrystalline cellulose, and crosscarmellose sodium to ensure uniform distribution. ⚙️
Step 2 – Granulation:
Perform wet granulation using a binder (e.g., povidone) or direct compression, depending on tablet type. π§ͺ
Step 3 – Drying:
Dry the granules at low temperature (<60°C) to maintain stability and prevent degradation. π¬️
Step 4 – Lubrication:
Add lubricants like magnesium stearate and colloidal silicon dioxide to improve flow and compression properties. ⚖️
Step 5 – Compression:
Compress into tablets using rotary tablet press machines to achieve uniform hardness and weight. π
Step 6 – Coating (optional):
Film-coat for controlled release, protection from moisture, or taste masking (especially in ODTs). π¨
Step 7 – Packaging:
Pack in blister packs or HDPE bottles with desiccants to ensure stability and protect from moisture. π¦
7️⃣ What is the appropriate dosage form of Zolpidem Tartrate? ππ
The appropriate dosage form depends on patient needs, onset requirements, and convenience:
-
Immediate-Release (IR) Tablets:
-
Most common for short-term insomnia treatment π
-
Allows rapid sleep induction within 15–30 minutes
-
-
Extended-Release (ER) Tablets:
-
Suitable for patients with difficulty maintaining sleep
-
Designed for sustained plasma levels overnight ⏱️
-
-
Orally Disintegrating Tablets (ODTs):
-
Ideal for patients with swallowing difficulties
-
Dissolve rapidly on the tongue π§
-
-
Sublingual Tablets / Sprays:
-
Rapid absorption for immediate effect π ⚡
-
π‘ Summary:
For most adults, immediate-release tablets are the preferred dosage form for Zolpidem, while ER or ODT forms are used based on patient-specific needs and ease of administration. ✅
8️⃣ When should Zolpidem Tartrate API (as medication) be taken? ⏰π
Although API itself isn’t consumed directly, formulations using Zolpidem Tartrate should follow:
-
Timing: Take immediately before bedtime (ensure 7–8 hours of sleep opportunity) π️
-
With or without food: Can be taken on an empty stomach for faster onset; food may delay absorption π½️
-
Adults: Typical dose 5–10 mg for immediate-release tablets, 6.25–12.5 mg for extended-release, depending on clinical response
-
Elderly/renally impaired: Lower doses recommended due to increased sensitivity ⚖️
⚠️ Precautions:
-
Avoid alcohol and other CNS depressants
-
Do not take if planning to wake up within 6–8 hours
-
Avoid activities requiring alertness the next morning (driving, operating machinery)
9️⃣ What are the effects and side effects of Zolpidem Tartrate? ⚡π΄
Therapeutic Effects:
-
Sleep induction: Reduces time to fall asleep
-
Sleep maintenance: In extended-release forms, improves total sleep duration π
-
Minimal muscle relaxation and anxiolysis compared to benzodiazepines — reduces daytime sedation risk
Common Side Effects:
-
Drowsiness, fatigue π΄
-
Dizziness, headache
-
Gastrointestinal issues: nausea, diarrhea
-
Mild amnesia or forgetfulness
Serious or Rare Side Effects:
-
Complex sleep behaviors: sleepwalking, sleep-driving π¨
-
Next-day sedation or impaired coordination
-
Allergic reactions or rash
-
Rare: hallucinations or mood changes
π‘ Management Tips:
-
Take lowest effective dose
-
Adequate sleep duration reduces next-day effects
-
Monitor elderly patients for falls or confusion
π How is Zolpidem Tartrate API tested? π§ͺ✅
Quality control ensures purity, potency, and safety before formulation:
-
Identity Tests:
-
IR spectroscopy, UV-Vis spectroscopy, HPLC retention time to confirm chemical structure
-
-
Assay / Potency:
-
HPLC determines API content (typically 98–102% of label claim)
-
-
Impurity Profile:
-
HPLC or LC-MS detects organic impurities and degradation products
-
Impurities controlled within ICH limits (<0.10% individually, <0.5% total)
-
-
Residual Solvent Testing:
-
Gas chromatography ensures solvents from synthesis are below safe limits
-
-
Physical Tests:
-
Melting point, loss on drying, water content
-
-
Microbiological Testing:
-
Total viable count, absence of pathogens (for sterility if needed)
-
π Outcome:
Every batch is released with a Certificate of Analysis (CoA) detailing these results, ensuring regulatory compliance. ✅
1️⃣1️⃣ What tests are performed on Zolpidem Tartrate API? ππ§«
| Category | Test | Purpose / Acceptance Criteria |
|---|---|---|
| Identity | IR, UV-Vis, HPLC retention | Confirm chemical structure |
| Assay / Potency | HPLC | 98–102% of label claim |
| Related Substances | HPLC / LC-MS | Individual <0.1%, total <0.5% |
| Residual Solvents | GC | Within ICH Q3C limits |
| Heavy Metals | ICP-OES | ≤10 ppm |
| Loss on Drying | Gravimetric | ≤0.5% |
| Melting Point | Capillary | ~193–196°C |
| Water Content | Karl Fischer | ≤0.5% |
| Microbial Limits | Plate count, absence of pathogens | Within pharmacopeial limits |
| Polymorphism | XRPD / DSC | Confirm correct crystalline form |
| Particle Size Distribution | Laser diffraction | Ensure uniformity for formulation |
π‘ Summary:
Zolpidem Tartrate API manufactured by Swapnroop Drugs & Pharmaceuticals undergoes rigorous chemical, physical, and microbiological testing to guarantee purity, stability, and suitability for formulation into hypnotic medications. ππ
1️⃣2️⃣ What are the challenges in manufacturing Zolpidem Tartrate API? ⚗️π
Producing high-quality Zolpidem Tartrate API involves several technical and regulatory challenges:
-
Multi-step synthesis complexity π
-
Requires condensation, cyclization, and amidation reactions.
-
Each step must be tightly controlled to prevent side reactions or impurity formation.
-
-
Impurity control π§ͺ
-
By-products from methylation, amidation, or cyclization can form.
-
Impurities must be kept within ICH guidelines (≤0.1% individually, ≤0.5% total).
-
-
Polymorphism control π
-
Zolpidem tartrate can crystallize in multiple forms.
-
Only a specific polymorph is pharmaceutically acceptable; controlling crystallization is critical.
-
-
Moisture sensitivity π§
-
Slightly hygroscopic; moisture can affect flow, assay, and stability.
-
Requires controlled drying and low-humidity storage.
-
-
Scale-up challenges ⚙️
-
Maintaining consistent yield, purity, and particle size from lab to industrial scale is demanding.
-
-
Regulatory compliance π️
-
All raw materials, solvents, and intermediates must meet GMP standards.
-
Residual solvents, heavy metals, and microbial limits must be documented for international regulatory submission.
-
1️⃣3️⃣ What are the challenges in manufacturing Zolpidem dosage forms? π⚙️
Formulating zolpidem into tablets, ODTs, or ER forms presents additional hurdles:
-
Poor water solubility π§
-
Zolpidem has moderate solubility; needs micronization, solid dispersions, or surfactants to enhance bioavailability.
-
-
Content uniformity ⚖️
-
Fine particle size can lead to non-uniform mixing, especially in ODTs and ER tablets.
-
Requires precise blending and granulation.
-
-
Stability during storage π‘️
-
Sensitive to moisture and light, which can affect dissolution rate and potency.
-
Film coatings and moisture-proof packaging are essential.
-
-
Excipients compatibility π§©
-
Some binders or fillers may interact with API and alter dissolution or stability.
-
Extensive pre-formulation studies are needed.
-
-
Controlled-release formulations ⏱️
-
ER tablets require careful polymer matrix selection and coating thickness control to maintain predictable drug release kinetics.
-
1️⃣4️⃣ What are the storage conditions for Zolpidem Tartrate API? π¦π‘️
To maintain stability, potency, and purity:
-
Temperature: Store in a cool environment (<25°C) π§
-
Moisture: Protect from humidity (slightly hygroscopic) π§
-
Light: Keep away from direct sunlight ☀️
-
Containers: Use airtight, light-resistant HDPE drums or polyethylene-lined fiber drums π’️
-
Handling: Avoid prolonged exposure to air or strong oxidizing agents ⚗️
Proper storage ensures chemical integrity and consistent performance during formulation. ✅
1️⃣5️⃣ What is the packaging for Zolpidem Tartrate API? π¦π
Packaging specifications for commercial API supply:
-
Inner lining: Double-layer polyethylene bags to prevent moisture ingress π§΄
-
Outer container: HDPE drum or fiberboard drum (25 kg typical) π’️
-
Labeling: Batch number, manufacturing and expiry date, handling instructions, regulatory compliance marks π·️
-
Special considerations:
-
Desiccants may be included to control residual moisture
-
Light-protective liners for long-term storage
-
πΏ Swapnroop Drugs & Pharmaceuticals ensures:
-
GMP-compliant packaging
-
Protection during storage and transport
-
Regulatory-ready CoA and documentation
1️⃣6️⃣ What is the shelf life of Zolpidem Tartrate API? π
The typical shelf life of Zolpidem Tartrate API is 3 to 5 years when stored under recommended conditions. Proper shelf life ensures that the API maintains potency, purity, and stability throughout its intended use.
Factors influencing shelf life:
-
Temperature control π‘️
-
Must be stored below 25°C in a cool environment.
-
-
Moisture protection π§
-
Slightly hygroscopic; moisture can reduce stability or affect particle flow.
-
-
Light exposure ☀️
-
Protected from direct sunlight to avoid degradation.
-
-
Packaging quality π¦
-
HDPE/fiber drums with double polyethylene liners preserve integrity.
-
-
Residual solvents & excipients ⚗️
-
Proper purification and drying ensure minimal degradation risk.
-
Stability confirmation π¬
-
Accelerated and long-term stability studies are performed following ICH Q1A(R2) guidelines.
-
Parameters monitored: assay, impurity profile, moisture content, polymorphic form, and color/appearance.
-
Ensures API remains within specification limits over the declared shelf life. ✅
π‘ Summary:
When stored under recommended conditions, Zolpidem Tartrate API from Swapnroop Drugs & Pharmaceuticals is stable, pure, and fully potent for 3–5 years, making it suitable for long-term formulation and distribution worldwide. ππ

Comments
Post a Comment